Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
Location: United States, California, Brisbane
Total raised: $60M
Investors 1
| Date | Name | Website |
| 16.09.2024 | ARCH Ventu... | archventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.11.2023 | Series A | $60M | - |
Mentions in press and media 3
| Date | Title | Description |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |
| 01.11.2023 | Gate Bioscience Raises $60M in Series A Financing | Gate Biosciences, a Brisbane, CA-based biotechnology company creating medicines called Molecular Gates, raised $60M in Series A funding. The round was led by Versant Ventures and a16z Bio + Health, with participation from ARCH Venture Partn... |
| - | Gate Bioscience | “Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from e... |